Over the last decade, there has been an increasing recognition that results published in scientific journals often cannot be reproduced by other scientists. This has been called the “reproducibility crisis” and has been described in a number of studies. A 2016 Nature article reported that more than 70% of surveyed researchers tried and failed to reproduce another scientist's experiments, and more than half have failed to reproduce their own experiments. A 2021 study reported that fewer than half
Read More
Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant
Character Biosciences Raises $18M to Expand Precision Medicine Platform for Diseases of Aging
What You Should Know: - Character Biosciences (“Character”), a precision medicine platform for diseases of aging raises $18M in a new funding round led by Innovation Endeavors, alongside leading life sciences investors Section 32 and Catalio Capital Management. Formerly known as Clover Therapeutics, the company’s data-driven approach integrates genomics, deep phenotyping and machine learning for target and biomarker discovery. - The company will use the funding to advance the frontiers of
Read More
The Academy and Nuance Partner to Launch The AI Collaborative
What You Should Know: - The Health Management Academy (The Academy) has partnered with Nuance, a Microsoft company, to launch The AI Collaborative, which brings together senior leaders from the nation’s Leading Health Systems (LHS) who are deploying these technologies in the clinical and operational settings, as well as planning for future use-cases. - The collaborative brings together physician executives from leading hospital systems and other key stakeholders across the healthcare
Read More
Arcadia & Datavant Partner to Accelerate Whole-Person Care & Biopharma Research
What You Should Know: - Arcadia and Datavant today announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics. - This partnership will unlock fresh insights to accelerate whole-person care and biopharma research, extending Arcadia’s leadership in empowering a data-driven transformation of healthcare. - Datavant will allow clients to connect Arcadia data to other types of Real World Data
Read More
Divurgent Appoints Ed Marx as New CEO
What You Should Know: - Divurgent, a healthcare IT consulting company, today announced it has appointed Ed Marx, a renowned leader with more than 30 years of experience, as its new Chief Executive Officer (CEO). - In addition, Colin Konschak, company founder and CEO since 2007, will move to a new role as Executive Chairman of the Board of Directors. Ed Marx Background Ed Marx is an influential, veteran IT leader with deep experience in healthcare. He was the former Chief
Read More
How the Life Sciences Industry Can Boost Diversity and Inclusion Efforts
Although it is well established that diversity improves outcomes and drives excellence, implementing diversity lags behind in many industries, including life sciences and healthcare. Diversity is lacking across the entire field, from academic research to clinical work, composition of the workforce, and medical practice. This leads to worse health outcomes and fewer professional opportunities for underserved demographics, such as racial and ethnic minorities, women, and people with
Read More
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis. As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation
What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B. - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
Komodo & Datavant Partner to Unlock Real World Data Across Healthcare
What You Should Know: - Today, Komodo Health and Datavant are expanding their partnership to make it even easier for companies to bring together disparate datasets and unlock deeper insights to speed innovation and improve patient outcomes. Together, the companies are helping customers gain more value than ever before from their proprietary or third-party data by linking it with Komodo’s longitudinal patient journey data and advanced analytics platform – all without compromising patient
Read More
Viz.ai Raises $100M for Care Coordination Platform at $1.2B Valuation
What You Should Know: - Viz.ai, a San Francisco-based AI-powered disease detection and care coordination platform raises $1000M in Series D funding led by Tiger Global and Insight Partners. The round also included participation from Scale Ventures, Kleiner Perkins, Threshold, GV (formerly Google Ventures), Sozo Ventures, CRV, and Susa. - The new funds will be used to support Viz.ai’s significant growth trajectory, expand the Viz Platform to detect
Read More
